This inventor holds 3 USPTO granted patents and 2 EPO patents. Top assignees: University of Southampton, Imperial Innovations Limited. Active years: 2009-2015.
Location History:
- Maitland, AU (2012)
- Newcastle, AU (2009 - 2015)
Company Filing History:
Years Active: 2009-2015
Title: Peter Alexander Blanch Wark: Innovator in Respiratory Disease Therapies
Introduction
Peter Alexander Blanch Wark is a notable inventor based in Newcastle, Australia. He has made significant contributions to the field of respiratory disease therapies, holding a total of 3 patents. His work focuses on innovative treatments aimed at alleviating the effects of respiratory diseases.
Latest Patents
Wark's latest patents include an anti-virus therapy for respiratory diseases. This invention provides the use of IFN-β, an agent that increases the expression of IFN-β, or a polynucleotide capable of expressing IFN-β for the manufacture of a medicament. This medicament is intended for the treatment of rhinovirus-induced exacerbation of respiratory diseases such as asthma and chronic obstructive pulmonary disease. The treatment is delivered via airway methods, such as an aerosol nebulizer. Additionally, IFN-λ is also provided for the same therapeutic purpose.
Career Highlights
Throughout his career, Wark has worked with esteemed institutions, including the University of Southampton and Imperial Innovations Limited. His experience in these organizations has contributed to his expertise in respiratory therapies and innovations.
Collaborations
Wark has collaborated with notable colleagues, including Donna Elizabeth Davies and Sebastian Johnston. These partnerships have furthered his research and development efforts in the field of respiratory disease treatment.
Conclusion
Peter Alexander Blanch Wark is a distinguished inventor whose work in respiratory disease therapies has the potential to significantly impact patient care. His innovative approaches and collaborations highlight his commitment to advancing medical science.